epilepsy

Eisai fires back at G-BA rebuff of Fycompa

Eisai fires back at G-BA rebuff of Fycompa

Fierce Pharma

US FDA accepts Sunovion's resubmitted NDA for Stedesa for review

US FDA accepts Sunovion's resubmitted NDA for Stedesa for review

Pharmabiz

Lyrica matches UCB drug in Pfizer's latest epilepsy trial

Lyrica matches UCB drug in Pfizer's latest epilepsy trial

Fierce Pharma

Supernus Launches Oxtellar XR in the United States

Supernus Launches Oxtellar XR in the United States

Review Seeker

After 2 Drug Approvals, Can Supernus Deliver In 2013?

After 2 Drug Approvals, Can Supernus Deliver In 2013?

Seeking Alpha

Pfizer's once-daily Lyrica trial fails to meet goal

Pfizer's once-daily Lyrica trial fails to meet goal

Reuters

FDA approves Eisai's drug to treat epileptic seizures

FDA approves Eisai's drug to treat epileptic seizures

Yahoo/Reuters

Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight

Eisai’s Epilepsy Drug Helps Obese Patients Reduce Weight

Bloomberg

GW Pharma IDs promising epilepsy drug in cannabis

GW Pharma IDs promising epilepsy drug in cannabis

Fierce Biotech

Supernus rockets 130% on FDA update

Supernus rockets 130% on FDA update

Marketwatch